Biotransformation of methylxanthines in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms. Allocation of metabolic pathways to isoforms and inhibitory effects of quinolones

This publication has 24 references indexed in Scilit:

• Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity in vivo and in vitro
  Antimicrobial Agents and Chemotherapy, 1992
• Biotransformation of caffeine and theophylline in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms
  Biochemical Pharmacology, 1992
• Genetically engineered V79 Chinese hamster cells metabolically activate the cytostatic drugs cyclophosphamide and ifosfamide.
  Environmental Health Perspectives, 1990
• Effect of quinolones on caffeine disposition
  Clinical Pharmacology & Therapeutics, 1989
• Comparison of Caffeine Metabolism by Slices, Microsomes and Hepatocyte Cultures from Adult Human Liver
  Xenobiotica, 1989
• Caffeine and theophylline metabolism in newborn and adult human hepatocytes; comparison with adult rat hepatocytes
  Biochemical Pharmacology, 1988
• 4-quinolones inhibit biotransformation of caffeine
  European Journal of Clinical Pharmacology, 1988
• Biotransformation of caffeine by microsomes from human liver
  Biochemical Pharmacology, 1987
• Monoclonal antibodies for studies on xenobiotic and endobiotic metabolism: Cytochromes P-450 as paradigm
  Biochemical Pharmacology, 1985
• A simple test for acetylator phenotype using caffeine.
  British Journal of Clinical Pharmacology, 1984